Literature DB >> 16597671

The logistic transform for bounded outcome scores.

Emmanuel Lesaffre1, Dimitris Rizopoulos, Roula Tsonaka.   

Abstract

The logistic transformation, originally suggested by Johnson (1949), is applied to analyze responses that are restricted to a finite interval (e.g. (0,1)), so-called bounded outcome scores. Bounded outcome scores often have a non-standard distribution, e.g. J- or U-shaped, precluding classical parametric statistical approaches for analysis. Applying the logistic transformation on a normally distributed random variable, gives rise to a logit-normal (LN) distribution. This distribution can take a variety of shapes on (0,1). Further, the model can be extended to correct for (baseline) covariates. Therefore, the method could be useful for comparative clinical trials. Bounded outcomes can be found in many research areas, e.g. drug compliance research, quality-of-life studies, and pain (and pain relief) studies using visual analog scores, but all these scores can attain the boundary values 0 or 1. A natural extension of the above approach is therefore to assume a latent score on 0,1) having a LN distribution. Two cases are considered: (a) the bounded outcome score is a proportion where the true probabilities have a LN distribution on (0,1) and (b) the bounded outcome score on [0,1] is a coarsened version of a latent score with a LN distribution on (0,1). We also allow the variance (on the transformed scale) to depend on treatment. The usefulness of our approach for comparative clinical trials will be assessed in this paper. It turns out to be important to distinguish the case of equal and unequal variances. For a bounded outcome score of the second type and with equal variances, our approach comes close to ordinal probit (OP) regression. However, ignoring the inequality of variances can lead to highly biased parameter estimates. A simulation study compares the performance of our approach with the two-sample Wilcoxon test and with OP regression. Finally, the different methods are illustrated on two data sets.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16597671     DOI: 10.1093/biostatistics/kxj034

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  28 in total

1.  Jointly modeling longitudinal proportional data and survival times with an application to the quality of life data in a breast cancer trial.

Authors:  Hui Song; Yingwei Peng; Dongsheng Tu
Journal:  Lifetime Data Anal       Date:  2015-09-24       Impact factor: 1.588

2.  Improvement in latent variable indirect response modeling of multiple categorical clinical endpoints: application to modeling of guselkumab treatment effects in psoriatic patients.

Authors:  Chuanpu Hu; Bruce Randazzo; Amarnath Sharma; Honghui Zhou
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-06-20       Impact factor: 2.745

Review 3.  On the Comparison of Methods in Analyzing Bounded Outcome Score Data.

Authors:  Chuanpu Hu
Journal:  AAPS J       Date:  2019-08-26       Impact factor: 4.009

4.  The distribution and the functions of autobiographical memories: Why do older adults remember autobiographical memories from their youth?

Authors:  Tabea Wolf; Daniel Zimprich
Journal:  Eur J Ageing       Date:  2016-04-12

5.  Modeling near-continuous clinical endpoint as categorical: application to longitudinal exposure-response modeling of Mayo scores for golimumab in patients with ulcerative colitis.

Authors:  Chuanpu Hu; Omoniyi J Adedokun; Liping Zhang; Amarnath Sharma; Honghui Zhou
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-10-30       Impact factor: 2.745

6.  Applying Beta Distribution in Analyzing Bounded Outcome Score Data.

Authors:  Chuanpu Hu; Honghui Zhou; Amarnath Sharma
Journal:  AAPS J       Date:  2020-03-17       Impact factor: 4.009

7.  Predictive model of spread of Parkinson's pathology using network diffusion.

Authors:  S Pandya; Y Zeighami; B Freeze; M Dadar; D L Collins; A Dagher; A Raj
Journal:  Neuroimage       Date:  2019-03-06       Impact factor: 6.556

8.  Bounded outcome score modeling: application to treating psoriasis with ustekinumab.

Authors:  Chuanpu Hu; Newman Yeilding; Hugh M Davis; Honghui Zhou
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-06-18       Impact factor: 2.745

9.  Quality of life of childbearing age women and its associated factors: an application of seemingly unrelated regression (SUR) models.

Authors:  Sareh Keshavarzi; Seyyed Mohammad Taghi Ayatollahi; Najaf Zare; Farkhondeh Sharif
Journal:  Qual Life Res       Date:  2012-08-18       Impact factor: 4.147

10.  Using an Anchor to Improve Linear Predictions with Application to Predicting Disease Progression.

Authors:  Alex Karanevich; Jianghua He; Byron J Gajewski
Journal:  Rev Colomb Estad       Date:  2018 Jul-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.